Markers of Systemic Metabolic Dysfunction in Vitiligo and Their Potential Role in Disease Pathogenesis: A Narrative Review
Health Science Reports · 2026-10 · 9 (10)
DOI: 10.1002/hsr2.72950 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Science Reports, online erschienen am 25.09.2026. Verfasst von Federica Papaccio und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cutaneous Physiopathology and Integrated Center of Metabolomics Research San Gallicano Dermatological Institute, IRCCS Rome Italy. Die Arbeit nennt 209 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Vitiligo is a chronic autoimmune disease characterized by the progressive destruction of melanocytes, resulting in depigmented skin macules. While traditionally viewed as a cutaneous disorder driven by a specific CD8 + T cell‐mediated interferon‐γ (IFN‐γ) signature, emerging research suggests that vitiligo may be a systemic condition linked to metabolic syndrome (MetS) and broader metabolic dysregulation.
Methods
This review synthesizes current experimental and clinical evidence regarding systemic metabolic alterations in vitiligo. We analyzed studies investigating disruptions in glucose utilization, lipid profile imbalances, and amino acid metabolism, alongside their mechanistic links to oxidative stress and immune activation.
Results
Evidence indicates that metabolic dysfunction, including aberrant glucose metabolism and lipid alterations, precedes or exacerbates immune mobilization. Key systemic factors such as advanced glycation end‐products (AGEs), proinflammatory adipokines and reduced protective factors (vitamins and small antioxidants) create a permissive environment for melanocyte apoptosis. Furthermore, some studies concerning metabolic profiling reveal that systemic biomarkers (e.g., homocysteine, total cholesterol, LDL/HDL ratio, and urinary metabolites) correlate with disease activity and treatment response.
Conclusions
Vitiligo involves a complex interplay between systemic metabolic shifts and cutaneous autoimmunity. Integrating metabolic profiling into clinical practice offers a transformative approach for identifying subclinical abnormalities, discovering biomarkers for early diagnosis, and developing personalized management strategies that address the disease beyond its dermatological manifestations.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Cutaneous Physiopathology and Integrated Center of Metabolomics Research San Gallicano Dermatological Institute, IRCCS Rome Italy.
ORCID-Profile: Federica Papaccio, Simona Scano, Barbara Bellei
Zitieren
APA
Papaccio, F., Scano, S., & Bellei, B. (2026). Markers of Systemic Metabolic Dysfunction in Vitiligo and Their Potential Role in Disease Pathogenesis: A Narrative Review. Health Science Reports, 9(10). https://doi.org/10.1002/hsr2.72950
Vancouver
Papaccio F, Scano S, Bellei B. Markers of Systemic Metabolic Dysfunction in Vitiligo and Their Potential Role in Disease Pathogenesis: A Narrative Review. Health Science Reports. 2026;9(10). doi:10.1002/hsr2.72950
BibTeX
@article{Papaccio2026,
author = {Papaccio, Federica and Scano, Simona and Bellei, Barbara},
title = {Markers of Systemic Metabolic Dysfunction in Vitiligo and Their Potential Role in Disease Pathogenesis: A Narrative Review},
journal = {Health Science Reports},
year = {2026},
volume = {9},
number = {10},
doi = {10.1002/hsr2.72950}
}
EUVIMED